MYCN and neuroblastoma: The pre-treatment risk stratification for this cancer relies on the International Neuroblastoma Risk Group (INRG) classification system, including age at diagnosis, histologic category, grade of tumor differentiation, tumor cell ploidy, 11q aberration and status of the oncogene MycN [2,10,11].